Park Square has placed Amanda Kay, Ph.D., as Chief Business Officer at Deep Genomics.
| less than a minute read
Amanda Kay Appointed Chief Business Officer of Deep Genomics, Tasked with Overseeing Expansion of Partnership Strategy
Get in touch
Get in touch
Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today the appointment of Amanda Kay, Ph.D., to the newly created role of Chief Business Officer.
Get in touch
Get in touch
Latest Insights
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-04-15-32-04-091-6a7205f4b4306b41266d92f2.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-04-18-23-13-222-6a722e11663e81e26a6b2c3e.jpg)
